Medical management of pituitary adenomas: Structural and ultrastructural changes

被引：13
作者：
Asa S.L. [1 ]
Ezzat S. [2 ]
机构：
[1] Dept. Laboratory Med./Pathobiology, University of Toronto, University of Health Network, Toronto, Ont. M5G 2M9
[2] Department of Medicine, University of Toronto, Princess Margaret Hospital, Toronto, Ont.
来源：
Pituitary | 2002年 / 5卷 / 2期
关键词：
Inhibition; Morphology; Stimulation; Therapy;
D O I：
10.1023/A:1022320732718
中图分类号：
学科分类号：
摘要：
The morphology of the various pituitary cell types is highly dynamic and allows recognition of many cellular functions. Most pituitary cells show morphologic changes that reflect stimulation or inhibition by hormones. Drugs have also been shown to alter the morphology of several pituitary tumor types, allowing a measure of therapeutic efficiency and a careful dissection of the mechanisms of action of various medical therapies. In some cases, these morphologic alterations can evoke diagnostic problems.
引用
收藏
页码：133 / 139
页数：6
相关论文
共 44 条
  • [1] Scheithauer B.W., Kovacs K., Randall R.V., Ryan N., Effects of estrogen on the human pituitary: A clinicopathologic study, Mayo Clin. Proc., 64, pp. 1077-1084, (1989)
  • [2] Kovacs K., Stefaneanu L., Ezzat S., Smyth H.S., Prolactin-producing pituitary adenoma in a male-to-female transsexual patient with protracted estrogen administration. A morphologic study, Arch. Pathol. Lab. Med., 118, pp. 562-565, (1994)
  • [3] Kovacs K., Stefaneanu L., Horvath E., Et al., Effect of dopamine agonist medication on prolactin producing pituitary adenomas. A morphological study including immunocytochemistry, electron microscopy and in situ hybridization, Virchows Arch. [A], 418, pp. 439-446, (1991)
  • [4] Tindall G.T., Kovacs K., Horvath E., Thorner M.O., Human prolactin-producing adenomas and bromocriptine: A histological, immunocytochemica, ultrastructural and morphometric study, J. Clin. Endocrinol. Metab., 55, pp. 1178-1183, (1982)
  • [5] Asa S.L., Kovacs K., Horvath E., Singer W., Smyth H.S., Hormone secretion in vitro by plurihormonal pituitary adenomas of the acidophil cell line, J. Clin. Endocrinol. Metab., 75, pp. 68-75, (1992)
  • [6] Horvath E., Kovacs K., Fine structural cytology of the adenohypophysis in rat and man, J. Electron. Microsc. Tech., 8, pp. 401-432, (1988)
  • [7] Yang H.-J., Ozawa H., Kurosumi K., Ultrastructural changes in growth hormone cells in the rat anterior pituitary after thyroidectomy as studied by immunoelectron microscopy and enzyme histochemistry, J. Clin. Electr. Microsco., 22, pp. 269-283, (1989)
  • [8] Loras B., Li J.Y., Durand A., Trouillas J., Sassolas G., Girod C., GRF et adénomes somatotropes humains. Corrélations in vivo et in vitro entre la libération de GH et les aspects morphologiques et immunocytochimiques, Ann. Endocrinol. (Paris), 46, pp. 373-382, (1985)
  • [9] Kawakita S., Asa S.L., Kovacs K., Effects of growth hormone-releasing hormone (GHRH) on densely granulated somatotroph adenomas and sparsely granulated somatotroph adenomas in vitro: A morphological and functional investigation, J. Endocrinol. Invest., 12, pp. 443-448, (1989)
  • [10] Ezzat S., Horvath E., Harris A.G., Kovacs K., Morphological effects of octreotide on growth hormone-producing pituitary adenomas, J. Clin. Endocrinol. Metab., 79, pp. 113-118, (1994)
12345